日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

更正:CXCR2拮抗剂navarixin联合pembrolizumab治疗特定晚期实体瘤:一项II期随机试验

Armstrong, Andrew J; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller, Wilson H Jr; Hansen, Aaron R; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

CXCR2拮抗剂navarixin联合pembrolizumab治疗特定晚期实体瘤:一项II期随机试验

Armstrong, Andrew J; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller, Wilson H Jr; Hansen, Aaron R; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S

A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)

一项针对晚期实体恶性肿瘤的 1 期研究,评估 veliparib (ABT-888) 联合每周卡铂和紫杉醇的疗效,并在三阴性乳腺癌 (TNBC) 中开展扩展队列研究 (ETCTN 8620)

Malhotra, Monica K; Pahuja, Shalu; Kiesel, Brian F; Appleman, Leonard J; Ding, Fei; Lin, Yan; Tawbi, Hussein A; Stoller, Ronald G; Lee, James J; Belani, Chandra P; Chen, Alice P; Giranda, Vincent L; Shepherd, Stacie Peacock; Emens, Leisha A; Ivy, S Percy; Chu, Edward; Beumer, Jan H; Puhalla, Shannon

A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

一项针对携带 BRCA1 或 BRCA2 突变的癌症患者或铂类耐药性卵巢癌或三阴性乳腺癌患者的长期单药维利帕尼 (ABT-888) 的 I 期药效学研究

Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji, Jiuping; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H

A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study

维利帕尼 (ABT-888) 联合放疗和替莫唑胺治疗新诊断的弥漫性脑桥胶质瘤的 I/II 期研究:一项儿童脑肿瘤联盟研究

Patricia A Baxter, Jack M Su, Arzu Onar-Thomas, Catherine A Billups, Xiao-Nan Li, Tina Young Poussaint, Edward R Smith, Patrick Thompson, Adekunle Adesina, Pete Ansell, Vincent Giranda, Arnold Paulino, Lindsey Kilburn, Ibrahim Quaddoumi, Alberto Broniscer, Susan M Blaney, Ira J Dunkel, Maryam Foulad

Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study

维利帕尼联合全脑放射治疗治疗非小细胞肺癌脑转移患者:一项随机、全球、安慰剂对照研究的结果

Chabot, Pierre; Hsia, Te-Chun; Ryu, Jeong-Seon; Gorbunova, Vera; Belda-Iniesta, Cristobal; Ball, David; Kio, Ebenezer; Mehta, Minesh; Papp, Katherine; Qin, Qin; Qian, Jane; Holen, Kyle D; Giranda, Vince; Suh, John H

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale

一项随机II期研究,比较维利帕尼联合替莫唑胺或卡铂/紫杉醇与安慰剂联合卡铂/紫杉醇治疗BRCA1/2转移性乳腺癌的疗效:设计和原理

Isakoff, Steven J; Puhalla, Shannon; Domchek, Susan M; Friedlander, Michael; Kaufman, Bella; Robson, Mark; Telli, Melinda L; Diéras, Véronique; Han, Hyo Sook; Garber, Judy E; Johnson, Eric F; Maag, David; Qin, Qin; Giranda, Vincent L; Shepherd, Stacie P

A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)

一项评估维利帕尼(ABT-888)联合卡铂/紫杉醇治疗日本非小细胞肺癌(NSCLC)患者的药代动力学和初步疗效的 1 期研究

Mizugaki, Hidenori; Yamamoto, Noboru; Nokihara, Hiroshi; Fujiwara, Yutaka; Horinouchi, Hidehito; Kanda, Shintaro; Kitazono, Satoru; Yagishita, Shigehiro; Xiong, Hao; Qian, Jane; Hashiba, Hideyuki; Shepherd, Stacie P; Giranda, Vincent; Tamura, Tomohide

A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report

维利帕尼 (ABT-888) 和替莫唑胺治疗复发性中枢神经系统肿瘤患儿的 I 期试验:儿童脑肿瘤联盟报告

Jack M Su, Patrick Thompson, Adekunle Adesina, Xiao-Nan Li, Lindsay Kilburn, Arzu Onar-Thomas, Mehmet Kocak, Brenda Chyla, Evelyn McKeegan, Katherine E Warren, Stewart Goldman, Ian F Pollack, Maryam Fouladi, Alice Chen, Vincent Giranda, James Boyett, Larry Kun, Susan M Blaney

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer

在转移性去势抵抗性前列腺癌患者中,采用维利帕尼(ABT-888)和替莫唑胺联合治疗靶向DNA修复

Hussain, Maha; Carducci, Michael A; Slovin, Susan; Cetnar, Jeremy; Qian, Jiang; McKeegan, Evelyn M; Refici-Buhr, Marion; Chyla, Brenda; Shepherd, Stacie P; Giranda, Vincent L; Alumkal, Joshi J